Nepalese authorities ordered Patanjali Ayurveda, the firm owned by Yoga guru Ramdev, to recall six of its products as they reportedly failed microbial tests and were found to be of ‘substandard’ quality. Nepal’s Department of Drug Administration ordered Patanjali Ayurveda to immediately recall the products. But Patanjali declined these allegations as wrong.

According to a local media report, the six products made by Divya Pharmacy in Uttarakhand failed the quality test and were found to be substandard by the authorities. Apart from Patanjali’s six products, another Indian medicine failed the test too. This was found to be a Bangalore based firm’s product Bactoclav of Micro Lab Limited.

The six products of Patanjali Ayurveda which have come under fire for failing microbial tests are Amla Churna of batch no AMC067, Divya Gashar Churna of batch no A-GHCI31, Bahuchi Churna of batch no BKC 011, Triphala Churna of batch no A-TPC151, Aswangandha of batch no AGC 081 and Adviya Churna of batch no DYC 059.

Soon after the result was declared, Department of Drug Administration ordered the Patanjali unit in Kathmandu to inform the headquarters and facilitate recalling of the products as per the provisions of the local medicine laws. Following this they also informed the stakeholders about the situation and asked them not to indulge in selling or prescribing the aforementioned six products.

Even in India itself, two Patanjali products were found to be substandard namely Divya Amla Juice and Shivlingi Beej. This was the result of an RTI reply that revealed that nearly 40 percent of Ayurveda products were of substandard quality. While Patanjali in its reply to these reports denied the claims.